Résultats de la recherche
10
Tout
Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved
26 mars 2025 17h00 HE
|
Cingulate Inc.
In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in Working Capital; Cash Runway Extending into Q4, Well Beyond Target Date for...
Connected Drug Delivery Devices Patent Landscape Report 2024: Market is Expanding with the United States Leading with 5,000+ Patents Emphasizing Bluetooth and NFC for Enhanced Connectivity
10 mars 2025 12h09 HE
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Connected Drug Delivery Devices Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering.The global connected drug...
Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025
04 mars 2025 09h00 HE
|
Cingulate Inc.
Results Have Been Submitted Ahead of In-Person Meeting with FDA Set for April 2 CTx-1301 is the First, True, Once-Daily Stimulant Medication to Treat ADHD Over the Entire Active Day KANSAS CITY,...
Pharmaceutical Cartridges Research Report 2024: Global Market to Reach $2.8 Billion by 2030 - Growing Adoption of Dual-Chamber Cartridges for Lyophilized Drugs and Reconstitution Expands Opportunities
09 janv. 2025 04h06 HE
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Cartridges - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Final Study Completed for Cingulate’s Lead Asset CTx-1301
07 janv. 2025 07h30 HE
|
Cingulate Inc.
No Serious Adverse Events ReportedSubmission of New Drug Application Targeted for Mid 2025 KANSAS CITY, Kan., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical...
Oral Proteins and Peptides Market Report 2025: Key Trends Shaping the Market Over the Next Ten Years and Beyond
02 janv. 2025 04h22 HE
|
Research and Markets
Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Oral Proteins and Peptides Market Report" has been added to ResearchAndMarkets.com's offering.The oral proteins and peptides market size has grown...
1,202 Drug Delivery Collaboration and Licensing Deals Trends Report and Directory 2024 by Company A-Z, Deal Type and Therapeutic Target
31 déc. 2024 05h31 HE
|
Research and Markets
Dublin, Dec. 31, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Drug Delivery Collaboration and...
India Drug Delivery Devices Market 2024, with Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma
10 déc. 2024 07h25 HE
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "India Drug Delivery Devices Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029
08 nov. 2024 11h32 HE
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic...
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
07 nov. 2024 07h30 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...